CEFOBID IN PLASTIC CONTAINER (nda050613)- (EQ 40MG BASE/ML,EQ 20MG BASE/ML)

Generic Name	CEFOPERAZONE SODIUM	Innovator	PFIZER
Dosage	EQ 40MG BASE/ML,EQ 20MG BASE/ML
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	CEFOBID is indicated for the treatment of the following infections: Respiratory Tract Infections, Peritonitis and Other Intra-abdominal Infections, Bacterial Septicemia, Infections of the Skin and Skin Structures, Pelvic Inflammatory Disease, Endometritis, and Other Infections of the Female Genital Tract, Urinary Tract Infections, Enterococcal Infections when caused by various susceptible organisms.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 40MG BASE/ML	**	**	-	-	-
EQ 20MG BASE/ML	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of CEFOBID IN PLASTIC CONTAINER